000
| 01119nam##2200241za#4500 |
---|
001 | 9.700029 |
---|
003 | CaOODSP |
---|
005 | 20210625000641 |
---|
007 | cr ||||||||||| |
---|
008 | 150407|2014||||xxc|||||o f|0| 0 eng|d |
---|
020 | |a978-1-100-25191-2 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-1/10-1-2014E-PDF |
---|
110 | 2 |aPublic Health Agency of Canada. |
---|
245 | 10|aSupplementary statement concerning the laboratory diagnosis of Lymphgranuloma Venereum (LGV) : |h[electronic resource]|bCanadian guidelines on sexually transmitted infections |
---|
260 | |aOttawa - Ontario : |bPublic Health Agency of Canada |cOctober 2014. |
---|
300 | |a2p. |
---|
590 | |a15-05|b2015-01-30 |
---|
690 | 07|aSexually transmitted diseases|2gcpds |
---|
775 | 08|tDéclaration supplémentaire concernant la diagnostic en laboratoire de la Lymphogranulomatose Vénérienne (LGV) : |w(CaOODSP)9.643944 |
---|
794 | |tCanadian guidelines on sexually transmitted infections |w(CaOODSP)9.848935 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s140 KB|uhttps://publications.gc.ca/collections/collection_2015/aspc-phac/HP40-1-10-1-2014-eng.pdf |
---|